Published in Psychopharmacology (Berl) on January 12, 2011
Habitat degradation impacts black howler monkey (Alouatta pigra) gastrointestinal microbiomes. ISME J (2013) 1.66
Neuroprotective effect of resveratrol in diabetic cerebral ischemic-reperfused rats through regulation of inflammatory and apoptotic events. Diabetol Metab Syndr (2014) 0.79
Novel Combinatorial Therapeutic Targeting of PAI-1 (SERPINE1) Gene Expression in Alzheimer's Disease. Mol Med Ther (2012) 0.78
Use of sodium butyrate as an alternative to dietary fiber: effects on the embryonic development and anti-oxidative capacity of rats. PLoS One (2014) 0.77
Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats. PLoS One (2013) 0.77
Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats. Psychopharmacology (Berl) (2012) 0.77
The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats. J Neuroinflammation (2016) 0.76
Silymarin ameliorates memory deficits and neuropathological changes in mouse model of high-fat-diet-induced experimental dementia. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.76
Ameliorative Effect of a Selective Endothelin ETA Receptor Antagonist in Rat Model of L-Methionine-induced Vascular Dementia. Korean J Physiol Pharmacol (2014) 0.75
Adenosine monophosphate-activated protein kinase activation mediates the leptin-induced attenuation of cognitive impairment in a streptozotocin-induced rat model. Exp Ther Med (2015) 0.75
In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator. Psychopharmacology (Berl) (2014) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol (1961) 45.34
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem (1979) 41.65
Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods (1984) 16.43
Improved method for the determination of blood glutathione. J Lab Clin Med (1963) 13.04
HDAC2 negatively regulates memory formation and synaptic plasticity. Nature (2009) 6.96
Recovery of learning and memory is associated with chromatin remodelling. Nature (2007) 6.72
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol (2004) 5.11
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov (2008) 4.43
Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology (2009) 3.64
Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci (2009) 2.95
Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther (2007) 2.90
Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke (2009) 2.30
Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol (2008) 2.29
Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem (2004) 2.21
Changing perspectives regarding late-life dementia. Nat Rev Neurol (2009) 2.04
Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol (2008) 1.91
Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology (2009) 1.84
Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep (1963) 1.82
Sodium 4-phenylbutyrate protects against cerebral ischemic injury. Mol Pharmacol (2004) 1.76
Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol Pharmacol (2006) 1.67
Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res (1998) 1.65
Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Curr Drug Targets CNS Neurol Disord (2005) 1.62
The effect of borderline diabetes on the risk of dementia and Alzheimer's disease. Diabetes (2007) 1.62
The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J Neurochem (2009) 1.53
The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses. BMC Cancer (2003) 1.48
Histone deacetylation in epigenetics: an attractive target for anticancer therapy. Med Res Rev (2005) 1.46
miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev (2010) 1.44
Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem (2002) 1.43
Functional differences in epigenetic modulators-superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron neuroprotection studies. J Med Chem (2007) 1.39
Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors. Neuropsychopharmacology (2008) 1.38
Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation. Neurobiol Dis (2007) 1.38
Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology (1999) 1.24
Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis (2010) 1.22
Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury. Exp Neurol (2007) 1.21
Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia. Mol Pain (2010) 1.19
Oxidative stress and vascular function: implications for pharmacologic treatments. Curr Hypertens Rep (2010) 1.18
HDAC inhibitors and neurodegeneration: at the edge between protection and damage. Pharmacol Res (2010) 1.15
Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR). Invest Ophthalmol Vis Sci (2010) 1.15
Streptozotocin diabetes in the mouse and guinea pig. Diabetes (1969) 1.10
Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res (1997) 1.10
Red cell and plasma cholinesterase activities in microsamples of human and animal blood determined simultaneously by a modified acetylthiocholine-DTNB procedure. Toxicol Appl Pharmacol (1970) 1.08
Targets for the prevention of dementia. J Alzheimers Dis (2010) 1.07
Type 2 diabetes, related conditions, in relation and dementia: an opportunity for prevention? J Alzheimers Dis (2010) 1.05
Histone deacetylases govern cellular mechanisms underlying behavioral and synaptic plasticity in the developing and adult brain. Behav Pharmacol (2010) 1.00
Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes (2010) 1.00
Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition. J Trauma (2008) 0.98
Inhibition of histone deacetylation protects wild-type but not gelsolin-deficient neurons from oxygen/glucose deprivation. J Neurochem (2006) 0.97
Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions. J Diabetes Complications (2010) 0.96
Potentiation of vascular oxidative stress and nitric oxide-mediated endothelial dysfunction by high-fat diet in a mouse model of estrogen deficiency and hyperandrogenemia. J Am Soc Hypertens (2010) 0.94
Expression changes of growth-associated protein-43 (GAP-43) and mitogen-activated protein kinase phosphatase-1 (MKP-1) and in hippocampus of streptozotocin-induced diabetic cognitive impairment rats. Exp Neurol (2007) 0.93
Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Biomed Pharmacother (2010) 0.91
Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells. Biomed Pharmacother (2010) 0.89
Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment. Cell Mol Neurobiol (2006) 0.88
Water extract of Triticum aestivum L. and its components demonstrate protective effect in a model of vascular dementia. J Med Food (2010) 0.87
Endothelial dysfunction: A potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease? Curr Opin Investig Drugs (2009) 0.86
Healthy brain aging: a road map. Clin Geriatr Med (2010) 0.85
Sesamol suppresses neuro-inflammatory cascade in experimental model of diabetic neuropathy. J Pain (2010) 0.84
Diabetes synergistically exacerbates poststroke dementia and tau abnormality in brain. Neurochem Int (2010) 0.84
The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain. Neuro Endocrinol Lett (2010) 0.84
[Dementia and insulin resistance in patients with diabetes mellitus]. Nihon Rinsho (2010) 0.83
Molecular targets for diabetes mellitus-associated erectile dysfunction. Mol Cell Proteomics (2009) 0.83
Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats. BMC Pharmacol (2008) 0.83
The link between iron, metabolic syndrome, and Alzheimer's disease. J Neural Transm (Vienna) (2010) 0.82
Alzheimer's disease and endothelial dysfunction. Neurol Sci (2009) 0.82
Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia. Pharmacol Biochem Behav (2008) 0.82
Eplerenone improves vascular function and reduces platelet activation in diabetic rats. J Physiol Pharmacol (2010) 0.81
3',4'-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta. Life Sci (2009) 0.80
Influence of metformin on GLUT1 gene and protein expression in rat streptozotocin diabetes mellitus model. Arch Physiol Biochem (2010) 0.79
H3K9 acetylation and radial chromatin positioning. J Cell Physiol (2009) 0.79
Vascular dementia. Top Stroke Rehabil (2008) 0.79
Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes. Curr Neurovasc Res (2010) 0.79
Attenuated alpha-adrenoceptor-mediated arterial and venous constrictions in rat models of diabetes. Eur J Pharmacol (2010) 0.78
Protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes. J Biol Regul Homeost Agents (2010) 0.77
Oral administration of grape seed proanthocyanidin extracts downregulate RAGE dependant nuclear factor- kappa BP65 expression in the hippocampus of streptozotocin induced diabetic rats. Exp Clin Endocrinol Diabetes (2008) 0.76
Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology (2011) 1.38
Animal models of acute renal failure. Pharmacol Rep (2012) 1.25
Accelerating harm reduction interventions to confront the HIV epidemic in the Western Pacific and Asia: the role of WHO (WPRO). Harm Reduct J (2008) 1.23
Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications. Vascul Pharmacol (2010) 1.22
Animal models of neuropathic pain. Fundam Clin Pharmacol (2011) 1.20
Risk factors of tuberculosis among health care workers in Sabah, Malaysia. Tuberculosis (Edinb) (2004) 1.16
Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res (2013) 1.03
Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice. Behav Brain Res (2007) 1.02
Role of phosphoinositide 3-kinase in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked behavioral deficits in mice. Pharmacol Rep (2007) 0.97
A review on animal models for screening potential anti-stress agents. Neurol Sci (2011) 0.97
Drug therapy of neuropathic pain: current developments and future perspectives. Curr Drug Targets (2014) 0.96
Extending pharmacological spectrum of opioids beyond analgesia: multifunctional aspects in different pathophysiological states. Neuropeptides (2011) 0.96
Reversal of memory deficits by Atorvastatin and Simvastatin in rats. Yakugaku Zasshi (2007) 0.95
Ameliorative effects of Ocimum sanctum in sciatic nerve transection-induced neuropathy in rats. J Ethnopharmacol (2008) 0.94
Role of different brain areas in peripheral nerve injury-induced neuropathic pain. Brain Res (2011) 0.94
Protective effect of Acorus calamus L. in rat model of vincristine induced painful neuropathy: an evidence of anti-inflammatory and anti-oxidative activity. Food Chem Toxicol (2011) 0.93
A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease. Bioorg Med Chem (2011) 0.92
Ameliorative effects of amiloride and pralidoxime in chronic constriction injury and vincristine induced painful neuropathy in rats. Eur J Pharmacol (2008) 0.91
Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property. J Renin Angiotensin Aldosterone Syst (2012) 0.90
Possible role of opioids and KATP channels in neuroprotective effect of postconditioning in mice. Biol Pharm Bull (2008) 0.89
Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil. J Psychopharmacol (2008) 0.89
Mast cells: an expanding pathophysiological role from allergy to other disorders. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.88
Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.87
Ameliorative potential of rosiglitazone in tibial and sural nerve transection-induced painful neuropathy in rats. Pharmacol Res (2009) 0.87
Exploring the ameliorative potential of Punica granatum in dextran sulfate sodium induced ulcerative colitis in mice. Phytother Res (2009) 0.87
Signal mechanism activated by erythropoietin preconditioning and remote renal preconditioning-induced cardioprotection. Mol Cell Biochem (2008) 0.87
Remote renal preconditioning-induced cardioprotection: a key role of hypoxia inducible factor-prolyl 4-hydroxylases. Mol Cell Biochem (2008) 0.87
Pharmacological investigations of Punica granatum in glycerol-induced acute renal failure in rats. Indian J Pharmacol (2011) 0.87
Antiamnesic effect of stevioside in scopolamine-treated rats. Indian J Pharmacol (2010) 0.85
Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats. Pharmacol Biochem Behav (2011) 0.85
Analgesic potential of intrathecal farnesyl thiosalicylic acid and GW 5074 in vincristine-induced neuropathic pain in rats. Food Chem Toxicol (2012) 0.85
Diethyl dithiocarbamic acid, a possible nuclear factor kappa B inhibitor, attenuates ischemic postconditioning-induced attenuation of cerebral ischemia-reperfusion injury in mice. Can J Physiol Pharmacol (2009) 0.84
Possible involvement of erythropoietin in remote renal preconditioning-induced cardioprotection in rats. J Cardiovasc Pharmacol (2008) 0.84
Liver X receptors: emerging therapeutic targets for Alzheimer's disease. Pharmacol Res (2013) 0.84
All-trans retinoic acid rescues memory deficits and neuropathological changes in mouse model of streptozotocin-induced dementia of Alzheimer's type. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.84
Memory restorative role of statins in experimental dementia: an evidence of their cholesterol dependent and independent actions. Pharmacol Rep (2010) 0.84
Studies on cerebral protection of digoxin against ischemia/reperfusion injury in mice. Yakugaku Zasshi (2009) 0.83
Therapeutic targets for the management of peripheral nerve injury-induced neuropathic pain. CNS Neurol Disord Drug Targets (2011) 0.83
Exploring the potential of telmisartan in chronic constriction injury-induced neuropathic pain in rats. Eur J Pharmacol (2011) 0.83
Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats. BMC Pharmacol (2008) 0.83
A review on renal toxicity profile of common abusive drugs. Korean J Physiol Pharmacol (2013) 0.82
Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia. Fundam Clin Pharmacol (2009) 0.82
Exploitation of HIV protease inhibitor Indinavir as a memory restorative agent in experimental dementia. Pharmacol Biochem Behav (2008) 0.82
Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer's disease. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.82
Neuroprotective effect of gadolinium: a stretch-activated calcium channel blocker in mouse model of ischemia-reperfusion injury. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.82
Regular rehearsal helps in consolidation of long term memory. J Sports Sci Med (2006) 0.82
Adaptogenic potential of curcumin in experimental chronic stress and chronic unpredictable stress-induced memory deficits and alterations in functional homeostasis. J Nat Med (2011) 0.81
Protective effects of caspase-9 and poly(ADP-ribose) polymerase inhibitors on ischemia-reperfusion-induced myocardial injury. Arch Pharm Res (2009) 0.80
Molecular aspects of ischaemic postconditioning. Fundam Clin Pharmacol (2009) 0.80
Reduction of ischemic, pharmacological and remote preconditioning effects by an antioxidant N-acetyl cysteine pretreatment in isolated rat heart. Yakugaku Zasshi (2008) 0.80
Implication of mast cell degranulation in ischemic preconditioning-induced prevention of cerebral injury. Fundam Clin Pharmacol (2008) 0.80
Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine H1 receptor activation-linked mechanism. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.80
Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuate opioid withdrawal in vivo and in vitro. Psychopharmacology (Berl) (2011) 0.80
Antinociceptive effect of Butea monosperma on vincristine-induced neuropathic pain model in rats. Toxicol Ind Health (2012) 0.80
Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia-hyperlipidemia induced vascular dementia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.80
Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: an evidence of anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects. BMC Complement Altern Med (2011) 0.79
Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet. PLoS One (2013) 0.79
Effects of erythropoietin on memory deficits and brain oxidative stress in the mouse models of dementia. Korean J Physiol Pharmacol (2010) 0.79
Ameliorative potential of Butea monosperma on chronic constriction injury of sciatic nerve induced neuropathic pain in rats. An Acad Bras Cienc (2012) 0.79
Neuroprotective effect of tadalafil, a PDE-5 inhibitor, and its modulation by L-NAME in mouse model of ischemia-reperfusion injury. J Surg Res (2013) 0.79
Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.79
Studies on effect of stress preconditioning in restrain stress-induced behavioral alterations. Yakugaku Zasshi (2010) 0.79
Modulation of neuroprotective effect of ischemic post-conditioning by dichlorobenzamil a Na(+)/Ca(2+) exchanger inhibitor in mice. Biol Pharm Bull (2010) 0.79
Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes. Curr Neurovasc Res (2010) 0.79
Ameliorative potential of sodium cromoglycate and diethyldithiocarbamic acid in restraint stress-induced behavioral alterations in rats. Pharmacol Rep (2011) 0.78
Reversal of pentylenetetrazole-induced seizure activity in mice by nickel chloride. Indian J Pharmacol (2009) 0.78
Ameliorative role of rosiglitazone in hyperhomocysteinemia-induced experimental cardiac hypertrophy. J Cardiovasc Pharmacol (2010) 0.78
Differential effect of spironolactone in chronic constriction injury and vincristine-induced neuropathic pain in rats. Eur J Pharmacol (2010) 0.78
Anti-stress effects of cilnidipine and nimodipine in immobilization subjected mice. Physiol Behav (2011) 0.78
Modulation of src-kinase attenuates naloxone-precipitated opioid withdrawal syndrome in mice. Behav Pharmacol (2011) 0.78
Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Behav Pharmacol (2008) 0.78
Exploring the potential effect of Ocimum sanctum in vincristine-induced neuropathic pain in rats. J Brachial Plex Peripher Nerve Inj (2010) 0.77
Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and biochemistry of hypertension induced vascular dementia in rats. Pharmacol Biochem Behav (2012) 0.77
Attenuating effect of hydroalcoholic extract of Acorus calamus in vincristine-induced painful neuropathy in rats. J Nat Med (2011) 0.77
Neuropathic pain-attenuating potential of aliskiren in chronic constriction injury model in rats. J Renin Angiotensin Aldosterone Syst (2012) 0.77
Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats. Psychopharmacology (Berl) (2012) 0.77
Neuropeptides as therapeutic targets to combat stress-associated behavioral and neuroendocrinological effects. CNS Neurol Disord Drug Targets (2014) 0.77
Pharmacological investigations on adaptation in rats subjected to cold water immersion stress. Physiol Behav (2011) 0.77
Investigating the role of endogenous opioids and KATP channels in glycerol-induced acute renal failure. Fundam Clin Pharmacol (2011) 0.76
Investigations into mild electric foot shock stress-induced cognitive enhancement: possible role of angiotensin neuropeptides. J Renin Angiotensin Aldosterone Syst (2012) 0.76
Pharmacological preconditioning by milrinone: memory preserving and neuroprotective effect in ischemia-reperfusion injury in mice. Arch Pharm Res (2010) 0.76
Alkaloids as aldose reductase inhibitors, with special reference to berberine. J Altern Complement Med (2013) 0.76
Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases. Curr Neuropharmacol (2015) 0.76
Ameliorative potential of pralidoxime in tibial and sural nerve transection-induced neuropathic pain in rats. Biol Pharm Bull (2010) 0.76
Pharmacological inhibition of inducible nitric oxide synthase attenuates the development of seizures in mice. Nitric Oxide (2009) 0.76
Pharmacology of Src family kinases and therapeutic implications of their modulators. Fundam Clin Pharmacol (2015) 0.76
Ameliorative potential of spironolactone in diabetes induced hyperalgesia in mice. Yakugaku Zasshi (2009) 0.76
Opioid withdrawal syndrome: emerging concepts and novel therapeutic targets. CNS Neurol Disord Drug Targets (2013) 0.76
Possible involvement of insulin, endogenous opioids and calcitonin gene-related peptide in remote ischaemic preconditioning of the brain. Yakugaku Zasshi (2007) 0.76
Implications of sodium hydrogen exchangers in various brain diseases. J Basic Clin Physiol Pharmacol (2015) 0.76
Pharmacological preconditioning of the brain: a possible interplay between opioid and calcitonin gene related peptide transduction systems. Pharmacol Rep (2009) 0.76
Effect of hydroalcoholic extract of Acorus calamus on tibial and sural nerve transection-induced painful neuropathy in rats. J Nat Med (2010) 0.76
Implicating the role of plasma membrane localized calcium channels and exchangers in stress-induced deleterious effects. Eur J Pharmacol (2013) 0.76
Experimental hypertension induced vascular dementia: pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor. Pharmacol Biochem Behav (2012) 0.76
Intrathecal delivery of farnesyl thiosalicylic acid and GW 5074 attenuates hyperalgesia and allodynia in chronic constriction injury-induced neuropathic pain in rats. Neurol Sci (2012) 0.76
Silymarin ameliorates memory deficits and neuropathological changes in mouse model of high-fat-diet-induced experimental dementia. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.76
Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Eur J Pharmacol (2008) 0.75
Neuroprotective effect of saponin rich extract of Acorus calamus L. in rat model of chronic constriction injury (CCI) of sciatic nerve-induced neuropathic pain. J Ethnopharmacol (2012) 0.75
Prolyl 4 hydroxylase: a critical target in the pathophysiology of diseases. Korean J Physiol Pharmacol (2013) 0.75
Potential of ezetimibe in memory deficits associated with dementia of Alzheimer's type in mice. Indian J Pharmacol (2009) 0.75